Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited June 30, 2021 Auto Bot Aduhelm (Drug), alzheimer's disease, Biogen Inc, Clinical Trials, Food and Drug Administration, Labeling and Labels (Product), your-feed-healthcare, your-feed-science 0 Even those who supported the F.D.A.’s approval of the controversial new drug said authorizing it for anyone with Alzheimer’s disease was much too broad.